(Q34466614)

2 August 2017

1 reference

title

Natural history of benign prostatic hyperplasia. (English)

1 reference

2 August 2017

3

Lieber MM

1 reference

2 August 2017

2

Girman CJ

1 reference

2 August 2017

1

Jacobsen SJ

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

58

1 reference

2 August 2017

issue

6 Suppl 1

1 reference

2 August 2017

page(s)

5-16; discussion 16

1 reference

Trends in prostatectomy for benign prostatic hyperplasia among black and white men in the United States: 1980 to 1994.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

New diagnostic and treatment guidelines for benign prostatic hyperplasia. Potential impact in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Urinary symptom and quality of life questions indicative of obstructive benign prostatic hyperplasia. Results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Validation of a new quality of life questionnaire for benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Natural history of prostatism: Factors associated with discordance between frequency and bother of urinary symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Natural history of prostatism: impact of urinary symptoms on quality of life in 2115 randomly selected community men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

The prevalence of prostatism: a population-based survey of urinary symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Results of an epidemiological survey using a modified American Urological Association symptom index for benign prostatic hyperplasia in France

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Prevalence of lower urinary tract symptoms in Austria as assessed by an open survey of 2,096 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Prevalence of lower urinary tract symptoms in Korean men in a community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

A community based study of prostatic symptoms in Singapore.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Correlates of urinary symptom scores in men

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

The development of human benign prostatic hyperplasia with age

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Follow-up of a cohort of men with untreated benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Natural history of prostatism: urinary flow rates in a community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Urinary flow rates and voiding pressures in elderly men living in a community

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Longitudinal changes in peak urinary flow rates in a community based cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Are Doctors Able to Assess Prostatic Size?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Accuracy in preoperative estimation of prostatic size. A comparative evaluation of rectal palpation, intravenous pyelography, urethral closure pressure profile recording and cystourethroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Inter-observer variation in assessment of the prostate by digital rectal examination

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Reproducibility and observer variability of transrectal ultrasound measurements of prostatic volume

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Determination of prostate volume with transrectal US for cancer screening. Part II. Accuracy of in vitro and in vivo techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Measurements of size and weight of prostate by means of transrectal ultrasonotomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Determination of prostate volume by transrectal ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Relationship between prostate specific antigen, prostate volume and age in the benign prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community dwelling men

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

The correlation between prostate volume, transition zone volume, transition zone index and clinical and urodynamic investigations in patients with lower urinary tract symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Ultrasonically determined patterns of enlargement in benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Parameters of Prostate Volume and Shape in a Community Based Population of Men 55 to 74 Years Old

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Virtual CT cystoscopy: color mapping of bladder wall thickness.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Controversies about indications for transurethral resection of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Significance of Prostatic Weight in Prostatism

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Some clinical aspects of uroflowmetry in elderly males. A population survey

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: results of community based studies in 2 countries

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Prostate-specific antigen (PSA), PSA density and age-adjusted PSA reference values in screening for prostate cancer--a study of a randomly selected population of 2,400 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Age-specific reference ranges for serum prostate-specific antigen in black men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Reference ranges for serum prostate-specific antigen in black and white men without cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

"BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Benign prostatic hyperplasia-associated prostate-specific antigen (BPSA) shows unique immunoreactivity with anti-PSA monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Natural history of prostatism: high American Urological Association Symptom scores among community-dwelling men and women with urinary incontinence.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Natural history of prostatism: risk factors for acute urinary retention

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Incidence rates and risk factors for acute urinary retention: the health professionals followup study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Relative contributions of incidence and survival to increasing prevalence of adult-onset diabetes mellitus: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

RE: "ALCOHOL CONSUMPTION, CIGARETTE SMOKING, AND RISK OF BENIGN PROSTATIC HYPERPLASIA"

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Accuracy of preoperative estimation of resection weight in transurethral prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Seasonal variation in the incidence of hip fracture among white persons aged 65 years and older in the United States, 1984-1987

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

Variations in medical care among small areas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901298-5

7 January 2021

10.1016/S0090-4295(01)01298-5

Identifiers

DOI

1 reference

2 August 2017

1 reference